15 May 2012, 9.30 AM
09.30 - 17.00
Venue: The Grosvenor, Buckingham Palace Road, London SW1W 0SJ
The Technology Strategy Board’s Innovation Platform on the Detection and Identification of Infectious Agents (DIIA) aims to reduce the morbidity, mortality and economic burden of infectious diseases in humans and animals.
Provisional figures released recently by the Health Protection Agency (HPA) show there were 9,042 new cases of tuberculosis (TB) in the UK in 2011. Compared to provisional numbers reported in 2010 (8,587), this is a five per cent increase. Early detection of TB and CAP could be the best way to reduce the impact on healthcare systems
DIIA is now looking to encourage in depth discussion and mutual understanding between researchers and the in-vitro diagnostics industry. The meeting is open to anyone from any sector with an interest in the early diagnosis of TB and CAP, including industry, businesses, managers, the public sector, academics and clinicians.
The meeting will offer considerable networking opportunity and registrants will be able to set up 1:1 bio-partnering meetings up-front to address the challenges - where there is capacity delegates will be allowed to set up meetings on the day but establishing meetings before is advised.
The workshop will aim to define the diagnostic capabilities that will shape the future management of TB and CAP in the UK and to inform DIIA’s third series of competitions
Confirmed speakers include, Professor Francis Drobniewski (Professsor of International Health and Tuberculosis at Barts and the London School of Medicine), Dr Vanya Gant (Consultant Microbiologist and Clinical Director in infection,University College London Hospital), Professor Peter Hawkey (Professor of Clinical and Public Health Bacteriology, Birmingham Heartlands Hospital), and Dr Jay Lewington (Chief Technology Officer, Smiths Detection Diagnostics).
To register for this workshop please follow this link